Is Globus Medical, Inc. (GMED) Overvalued?
We dive into why Globus Medical, Inc. (GMED) could be considered overvalued on 2026-07-23, based on AAII’s Value Score and Grade.Jenna Brashear
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jenna Brashear
Cynthia McLaughlin
Rosalio Madrigal
Michael Rose
| Share Statistics | GMED | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $11,056.5 | $377.3 | 78% |
|
| Shares Out (Mil) | 137.4 | 41.7 | 69% |
|
| Institutional Ownership | 82.9% | 77.8% | 51% |
|
| Float (Mil) | 111.7 | 34.7 | 63% |
|
| Beta | na | 0.86 | na |
|
| Avg Daily Volume (000s) | 1,478 | 307 | 76% |
|
| Price Change (52-week) |
55.9% | 64.3% | 80% |
|
| Growth | GMED | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 30.1% | 11.8% | 90% |
|
| Net Income (5yr) | 39.4% | (5.8%) | 90% |
|
| EPS (5yr) | 31.2% | 10.6% | 82 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (44.7%) | (16.0%) | 9% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 14 | 14 | 15 | |
| Current EPS | $1.180 | $4.905 | $5.297 | |
| Month Ago EPS | $1.170 | $4.742 | $5.145 | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 0 | 3 | 1 | |
| Three Months Ago EPS | $1.164 | $4.703 | $5.118 | |
| Year/Year Chg | 7.3% | 25.1% | 48.8% | |
| Financials | GMED | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,145 | $152 | 67% |
|
| Net Income (TTM) (Mil) | $535 | ($9) | 80% |
|
| EPS (TTM) | $3.971 | ($0.400) | 83% |
|
| Operating Cash Flow (TTM) (Mil) | $910 | ($2) | 80% |
|
| Net Cash Flow (TTM) (Mil) | $278 | $1 | 87% |
|
| Long-Term Debt (Q1) (Mil) | $97 | $22 | 44% |
|
| Enterprise Value (Q1) (Mil) | $10,277 | $304 | 75% |
|
| Valuation | GMED | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.32 | 2.92 | 55% |
|
| P/E | 21.1 | 29.9 | 52% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.7 | 1.5 | 32% |
|
| Ratios | GMED | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 69.2% | 59.0% | 80% |
|
| Net Margin | 17.0% | (6.9%) | 75% |
|
| ROA | 10.2% | (13.4%) | 88% |
|
| ROE | 11.8% | (13.5%) | 63% |
|
| Liabilities to Assets | 13.1% | 45.8% | 8% |
|
| F-Score | 8 | 4 | 93% |
|
Globus Medical, Inc. did not pass any screens on 8/7/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors